HGH Fragment 176-191
Pure lipolysis fragment.
- Sizes available
- 2mg · 5mg
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Equivalent to AOD-9604. Fat-loss only, with no IGF-1 elevation.
Mechanism · Native HGH 176-191 fragment. Lipolytic without anabolic or glucose side effects.
Mechanism, dose, ramp, risk.
- Mechanism
- Synthetic analogue of HGH C-terminal. Fat-mobilizing without GH receptor activation.Source · PEPVERA editorial
- Target dose
- 500 mcg / day, subq.Source · PEPVERA editorial
- Ramp
- Begin full dose. 8-week cycle.Source · PEPVERA editorial
- Risks
- Injection-site reaction.Source · PEPVERA editorial
Compared to its siblings.
HGH Fragment 176-191
Equivalent to AOD-9604. Fat-loss only, with no IGF-1 elevation.
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 4 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Pure Peptide UKUK | $14.4$7.20/mg · 2mg | In-house COA | 4 days | Out of stock |
| Pure Peptide UKUK | $28.5$5.70/mg · 5mg | In-house COA | 4 days | Out of stock |
| SwissChemsUS | $38.36$7.67/mg · 5mg | COA with shipment | 3 days | |
| Orion PeptidesUS | $49.99$10.00/mg · 5mg | COA with shipment | 3 days | Out of stock |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
0.25 mg / wk
Baseline ramp
Week 3–4
0.5 mg / wk
Hold, observe
Week 5–8
1.0–2.0 mg / wk
Ascend
Week 9–12
500 mcg / day, subq.
Terminus
Draw 8 units.
0.2 mg = 0.08 mL at 2.50 mg/mL. 25.0 doses per vial.
cut · X · SwissChems
HGH Fragment 176-191 · 5mg